Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PREVENT
NCT00000614Phase 3Completed
- Sponsor
- National Heart, Lung, and Blood Institute
- Start
- Sep 1998
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of warfarin in venous thromboembolism (VTE), sponsored by National Heart, Lung, and Blood Institute. Started Sep 1998; status: completed.
02
Drugs
warfarin
03
Conditions
venous thromboembolism (VTE)
Beyond the preview
Go deeper on NCT00000614.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00000614.